CYCCP logo Cyclacel Pharmaceuticals : CYCCP

CYCCP

Stock Data

$5.05

Change up

$0.00 (0.00%)

Asset Type

Preferred Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey.

All Cyclacel Pharmaceuticals Articles

1 Article

No articles found for Cyclacel Pharmaceuticals.